O. CÜRE Et Al. , "Factors Affecting Mortality in COVID-19 Patients Treated with Tocilizumab," Eastern Journal of Medicine , vol.29, no.3, pp.359-366, 2024
CÜRE, O. Et Al. 2024. Factors Affecting Mortality in COVID-19 Patients Treated with Tocilizumab. Eastern Journal of Medicine , vol.29, no.3 , 359-366.
CÜRE, O., İLKKILIÇ, K., Şen, B., ARPA, M., AYDIN, E., AVCI, U., ... TÜFEKÇİ, D.(2024). Factors Affecting Mortality in COVID-19 Patients Treated with Tocilizumab. Eastern Journal of Medicine , vol.29, no.3, 359-366.
CÜRE, OSMAN Et Al. "Factors Affecting Mortality in COVID-19 Patients Treated with Tocilizumab," Eastern Journal of Medicine , vol.29, no.3, 359-366, 2024
CÜRE, OSMAN Et Al. "Factors Affecting Mortality in COVID-19 Patients Treated with Tocilizumab." Eastern Journal of Medicine , vol.29, no.3, pp.359-366, 2024
CÜRE, O. Et Al. (2024) . "Factors Affecting Mortality in COVID-19 Patients Treated with Tocilizumab." Eastern Journal of Medicine , vol.29, no.3, pp.359-366.
@article{article, author={OSMAN CÜRE Et Al. }, title={Factors Affecting Mortality in COVID-19 Patients Treated with Tocilizumab}, journal={Eastern Journal of Medicine}, year=2024, pages={359-366} }